Veradigm Inc. (NASDAQ:MDRX – Get Free Report)’s share price was down 2.7% on Thursday . The stock traded as low as $9.05 and last traded at $9.05. Approximately 26,198 shares traded hands during trading, a decline of 98% from the average daily volume of 1,458,157 shares. The stock had previously closed at $9.30.
Analysts Set New Price Targets
Separately, StockNews.com began coverage on shares of Veradigm in a research note on Friday. They issued a “hold” rating for the company. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, Veradigm currently has an average rating of “Hold” and an average price target of $11.75.
Check Out Our Latest Analysis on MDRX
Veradigm Stock Performance
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Veradigm stock. Innealta Capital LLC purchased a new stake in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- Election Stocks: How Elections Affect the Stock Market
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- Do ETFs Pay Dividends? What You Need to Know
- Top 3 ETFs to Hedge Against Inflation in 2025
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.